In several malignancies, including colorectal cancer,25 urothelial carcinoma,26 thyroid cancer,27 endometrial cancer,28 and HCC,6 serum FGF21 levels are significantly elevated and associated with recurrence or advanced stages. This evidence concerns the gene FGF21 and urothelial carcinoma.